Delivery Order SPE2DB22D3011-SPE2DB25FP8MY
Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $7.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,155.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a completion date of February 6, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has extensive...
- This federal contract award, valued at $5,550.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN07K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,404,006 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,720.56 and is a Firm Fixed Price Delivery Order, with a period of performance through November 13, 2024....
- This federal contract award, with an ID of SPE2DB22D3004|SPE2DB25FPC99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $6,434.24 and is a Firm Fixed Price Delivery Order type contract, running through January 16, 2025. AmerisourceBergen holds a...
- This federal contract award, valued at $4,851.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $16,191.88 and is a firm-fixed-price delivery order with a completion date of June 13, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,294.67 firm fixed price delivery order is for the supply of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,746.04 firm fixed-price delivery order is for Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,923.82 firm fixed price delivery order is for ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with a set-aside program. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,077.74 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 14, 2025 and was awarded on March 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...